4th Quarter - Amendment — COHERUS BIOSCIENCES for COHERUS BIOSCIENCES, INC. (2025)

Firm

COHERUS BIOSCIENCES

Client

COHERUS BIOSCIENCES, INC.

Income

—

Expenses

$80,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report	Oct 22, 2025	$80,000	Replaced
4th Quarter - Amendment (this page)	Mar 9, 2026	$80,000	Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production

Lobbyist	Covered position, as disclosed
DAVID SANDERS	Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Defense, Dept of (DOD); Office of Science & Technology Policy (OSTP)

Government Issues GOV

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

Lobbyist	Covered position, as disclosed
DAVID SANDERS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Defense Advanced Research Projects Agency (DARPA); President of the U.S.; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Natl Security Council (NSC); Defense Nuclear Facilities Safety Board; SENATE; Executive Office of the President (EOP); White House Office; Food & Drug Administration (FDA); Federal Emergency Management Agency (FEMA); Energy, Dept of; Vice President of the U.S.

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.